Associate Professor of Medicine, at the University of Toronto
Co-founder of the Susan Leslie Clinic for Neuroendocrine Cancers at the Odette Cancer Centre Sunnybrook Health Sciences Centre
Dr. Simron Singh is an Associate Professor of Medicine, at the University of Toronto and co-founder of the Susan Leslie Clinic for Neuroendocrine Cancers at the Odette Cancer Centre Sunnybrook Health Sciences Centre. In addition, he is a principal investigator and associate scientist with the Institute for Clinical Evaluative Sciences and Sunnybrook Research Institute. In 2013, Dr. Singh joined Cancer Care Ontario (CCO) as the Provincial Head, Person-Centred Care Strategy responsible for the development and execution of CCO corporate strategic priority around person-centred care. He had numerous other board and administrative roles both at the national and international level.
Dr. Singh is the symposium chair for the North American Neuroendocrine Tumor Society as well as the co-chair of the Commonwealth Neuroendocrine Tumour Group. He is on Canadian Clinical Trial group NET disease site group co-chair as well as on the European Neuroendocrine Tumour Society advisory board. He currently is the co-chair of the Neuroendocrine Advisory Committee at Cancer Care Ontario which has been able to bring PRRT and Ga-68 imaging to Ontario.
Dr. Singh is an internationally recognized clinical and research leader in the field of neuroendocrine cancers. He is a leader in health services research and system level quality improvement and measurement. Dr. Singh has published in numerous high impact journals such as Lancet, Lancet Oncology, JAMA Oncology and the Journal of Clinical Oncology as lead or senior author. He has been the primary author of numerous guidelines to improve the care of NET patients. He holds a number of peer reviewed grants as well as clinical trial leadership positions. Dr. Singh has numerous international speaking invitations as well as leads a number of research and quality initiatives to improve the ongoing care of patients with cancer.